Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
THREAD is a leading global provider of decentralized clinical trial (DCT) and electronic clinical outcome assessment (eCOA) technology. The company's unified platform enables biopharmaceutical companies and contract research organizations to design, operate, and scale modern clinical research studies. By integrating features such as eConsent, telehealth, and remote patient monitoring, THREAD facilitates more inclusive and patient-centric trials. The company supports research across more than 60 countries, aiming to make clinical trials more efficient and accessible for participants and investigators alike. Following its acquisition by JLL Partners and Water Street Healthcare Partners, THREAD has expanded its capabilities through strategic acquisitions like Modus Outcomes and CureClick.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thread.